TrialCancer medicine2026

Heterogeneity in Treatment Effects of Reduced Versus Standard Dose of Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer.

Wataru Fukuokaya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.